BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IDE574 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IDE574\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07540572-2535@assetmemo.bio
DTSTAMP:20261121T004527Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:IDE574: Phase 1 readout est. (NCT07540572)
DESCRIPTION:IDE574\, phase 1.\nStudy: A Study to Investigate the Safety\, P
 harmacokinetics\, and Preliminary Efficacy of IDE574 Therapy in Adult Part
 icipants With Advanced Solid Tumors\nEstimated primary completion: 31 Dece
 mber 2029. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ide574#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0754057
 2
URL:https://assetmemo.bio/drug/ide574#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
